Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Relation Between Prostaglandin E2 Metabolite Levels and the Development of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Neonates

NCT07338370 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT07338370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07338370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Relation Between Prostaglandin E2 Metabolite Levels and the Development of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Neonates
Lead sponsor
Ain Shams University
Phase
Observational
Overall status
Recruiting
Start date
January 31, 2026
Completion date
April 30, 2026
Enrollment
34 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal prematurity, patent ductus arteriosus in preterm infants, prostaglandins